% | $
Quotes you view appear here for quick access.

Organovo Holdings, Inc. Message Board

  • dogdays_life dogdays_life Mar 20, 2013 10:14 AM Flag

    Checking in on Organovo by Seeking Alpha...

    long article and this is the conclusion...

    We see a significant opportunity for Organovo to create 3D cell assays and start introducing them to the market in 2014. We model the launch of one new major cell biology assay kit coming to market every year starting in 2014. We see each product as a potential $20 to $30 million opportunity for the company, and there are probably a dozen products within cell toxicology alone the company can create.

    We expect the company's top-line to be lumpy, but eventually take off in a hockey-stick like ramp starting in 2015 or 2016 based on two revenues sources: firstly, early-stage collaborations should start progressing to where Organovo can earn developmental milestones, and second, the company should launch cell assay tests in 2014 and 2015.

    We expect costs to remain low as management looks to partner with larger organizations and academic institutions. All this should make Organovo an attractive investment for long-term shareholders. We can justify a market value of $300 million given our estimating financial model. We wouldn't chase the stock here, but instead recommend investors use pull-backs to opportunistically establish a position.

3.88-0.02(-0.51%)Aug 26 4:00 PMEDT